Stock News•1 day ago
What a $227,000 GeneDx Insider Sale Means as Revenue Climbs 17%
GeneDx CFO sold 3,729 Class A shares (~$227K) on June 16, reducing his direct stake by 8.54%, even as revenue climbed 17%.
MarketLens
What Does Recent Insider Selling at Natera (NTRA) Signal to Investors
3 months ago
SHARE THIS ON:
Exclusive Content for Pro Members
Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.
SHARE THIS ON:
Related Articles
Category
You may also like
Stock News•1 week ago
Insiders Are Selling These 3 Stocks—Should Investors Be Concerned?
Insider sales are rising across three stocks—two large-caps in industrials and retail, plus a small-cap chip stock—signaling bearish sentiment, though severity varies by name.
Stock News•1 months ago
Natera, Inc. (NTRA) Q1 2026 Earnings Call Transcript
Natera, Inc. (NTRA) released its Q1 2026 earnings transcript, providing updated financial performance metrics and operational insights. Investors are reviewing the report to assess the company's growt...
Stock News•1 months ago
A Kailera Therapeutics (KLRA) Insider Scooped up an Additional 500,000 Shares for $8.0 Million
Kailera Therapeutics (KLRA) insider purchased 500,000 shares for $8.0 million, according to recent SEC filings. This significant acquisition by company leadership signals confidence in the clinical-st...
Breaking News
View All →Featured Articles
Top Headlines
Stock News•58 minutes ago
NVDA Who? Micron Blows Doors Off Q3 Earnings, Revs
Stock News•1 hour ago
Zoox to ramp up production of up to 100 newly upgraded robotaxis a week
Stock News•1 hour ago
Pfizer (PFE) Falls More Steeply Than Broader Market: What Investors Need to Know
Stock News•1 hour ago
3 Popular Stocks to Steer Clear Of
Stock News•2 hours ago